Study to Assess the Efficacy/Safety of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido

PHASE3CompletedINTERVENTIONAL

Enrollment

549

Participants

Timeline

Start Date

June 30, 2002

Primary Completion Date

October 31, 2003

Study Completion Date

October 31, 2003

Conditions

Hypoactive Sexual Desire Disorder (HSDD)

Interventions

DRUG

Testosterone Transdermal System

testosterone (300 mcg/day) patch replaced twice a week for two years

DRUG

Placebo patch

placebo patch replaced twice a week for two years

Trial Locations (3)

Research Facility, Chicago

Research Facility, Randwick

Research Facility, Québec